Severe hyperglycemia in an HIV clinic: Preexisting versus drug-associated diabetes mellitus

被引:19
作者
Kilby, JM [1 ]
Tabereaux, PB [1 ]
机构
[1] Univ Alabama, Div Infect Dis, Dept Med, Birmingham, AL 35294 USA
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1998年 / 17卷 / 01期
关键词
hyperglycemia; diabetes mellitus; human immunodeficiency virus; megestrol acetate; corticosteroids; pentamidine; didanosine;
D O I
10.1097/00042560-199801010-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We determined the frequency and clinical nature of severe hyperglycemia in a university clinic for HIV-l-infected patients. The medical records of 1392 adult HN-infected patients were reviewed for cases of severe hyperglycemia, defined as two or more serum glucose values >250 mg/dl or diabetes treatment during clinic care. Demographic information, family histories of diabetes mellitus, body weights, CD4(+) lymphocyte counts, and use of corticosteroids, megestrol acetate, pentamidine, or didanosine were recorded for subjects meeting the case definition. Comparisons were made between preexisting diabetic (group 1) and incident hyperglycemic cases (group ?). Less than 2% of the total clinic population experienced severe hyperglycemia: 12 in group 1 and 13 in group 2. Group 2 had lower body weights (mean, 70.6 kg versus 90.0 kg; p < 0.05) and more advanced HIV disease (mean CD4 count, 79/mm(3) versus 550/mm(3); p < 0.05) than group 1. Group 2 cases had evidence of drug-associated hyperglycemia; four cases demonstrated hyperglycemia coinciding with large fluctuations in weight during megestrol therapy. Among megestrol recipients, cases did not differ from noncases in demographics, weight, or CD4 count. Severe hyperglycemia is uncommon in adult HIV-infected patients. Approximately one half of these patients have preexisting diabetic conditions; many of the remainder may have drug-induced hyperglycemia, especially as a result of corticosteroids or megestrol acetate.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 20 条
[11]   INSULIN-DEPENDENT DIABETES-MELLITUS FOLLOWING PENTAMIDINE THERAPY IN A PATIENT WITH AIDS [J].
LIEGL, U ;
BOGNER, JR ;
GOEBEL, FD .
CLINICAL INVESTIGATOR, 1994, 72 (12) :1027-1029
[12]   REVERSIBLE DIABETES-MELLITUS AFTER INTRAVENOUS PENTAMIDINE [J].
MILLARD, PS ;
VANDERHORST, C .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (04) :442-442
[13]   HYPEROSMOLAR NONKETOTIC DIABETIC SYNDROME FOLLOWING TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION WITH DIDANOSINE [J].
MUNSHI, MN ;
MARTIN, RE ;
FONSECA, VA .
DIABETES CARE, 1994, 17 (04) :316-317
[14]   DIABETES-MELLITUS FOLLOWING INTRAVEAOUS PENTAMIDINE ADMINISTRATION IN A PATIENT WITH HIV-INFECTION [J].
NASTI, G ;
ZANETTE, G ;
INCHIOSTRO, S ;
DONADON, V ;
TIRELLI, U .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (06) :645-646
[15]   HYPERGLYCEMIA INDUCED BY MEGESTROL-ACETATE [J].
PANWALKER, AP .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (10) :878-878
[16]   HYPOGLYCEMIA AND DIABETES-MELLITUS FOLLOWING PARENTERAL PENTAMIDINE MESYLATE TREATMENT IN AIDS PATIENTS [J].
PERRONNE, C ;
BRICAIRE, F ;
LEPORT, C ;
ASSAN, D ;
VILDE, JL ;
ASSAN, R .
DIABETIC MEDICINE, 1990, 7 (07) :585-589
[17]   SECONDARY DIABETES-INDUCED BY MEGESTROL-ACETATE THERAPY IN A PATIENT WITH AIDS-ASSOCIATED CACHEXIA [J].
SALINAS, I ;
LUCAS, A ;
CLOTET, B .
AIDS, 1993, 7 (06) :894-894
[18]  
TROISVALLETS D, 1995, 35 INT C ANT AG CHEM
[19]   TRANSIENT INSULIN-DEPENDENT DIABETES-MELLITUS IN AN HIV-INFECTED PATIENT RECEIVING DIDANOSINE [J].
VITTECOQ, D ;
ZUCMAN, D ;
AUPERIN, I ;
PASSERON, J .
AIDS, 1994, 8 (09) :1351-1351
[20]   TRENDS IN DIABETES AND DIABETIC COMPLICATIONS, 1980-1987 [J].
WETTERHALL, SF ;
OLSON, DR ;
DESTEFANO, F ;
STEVENSON, JM ;
FORD, ES ;
GERMAN, RR ;
WILL, JC ;
NEWMAN, JM ;
SEPE, SJ ;
VINICOR, F .
DIABETES CARE, 1992, 15 (08) :960-967